Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta blockers in combination with class I antiarrhythmic agents.

P C Deedwania, A Y Olukotun, J Kupersmith

    The American Journal of Cardiology
    |August 31, 1987
    PubMed
    Summary

    Nadolol combined with antiarrhythmic drugs effectively reduced ventricular arrhythmias in patients poorly controlled by class I agents alone. This combination therapy demonstrated significant reductions in premature complexes and couplets, improving treatment response.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    An overview of interventional pulmonary embolism management in the United Kingdom in 2026.

    Clinical radiology·2026
    Same author

    Interventional Oncology Geographic Inequality-A Problem for Today.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026
    Same author

    IO1-UK: a cross-sectional study to re-evaluate the provision of interventional oncology services across the United Kingdom.

    Clinical radiology·2026
    Same author

    Time to Splenic Embolisation in Trauma Patients Arriving at a Major Trauma Centre In-Hours or Out-of-Hours: A UK Multicentre Study.

    Cardiovascular and interventional radiology·2026
    Same author

    Pictorial review of the use of percutaneous mechanical thromboaspiration in peripheral vascular occlusions.

    Clinical radiology·2025
    Same author

    Variation in paediatric splenic trauma management in adult and combined major trauma centres in England.

    Clinical radiology·2025

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Ventricular arrhythmias require effective treatment strategies.
    • Class I antiarrhythmic agents are commonly used but may be insufficient for some patients.
    • Evaluating drug interactions is crucial for optimizing antiarrhythmic therapy.

    Purpose of the Study:

    • To assess the hemodynamic and antiarrhythmic interactions between nadolol and class I antiarrhythmic agents (quinidine or procainamide).
    • To determine the efficacy of combination therapy in patients with poorly controlled ventricular arrhythmias.

    Main Methods:

    • A double-blind, parallel study involving 18 patients with ventricular arrhythmias.
    • Patients received either a class I agent alone or in combination with nadolol.
    • Treatment efficacy was assessed using radionuclide ventriculography and 24-hour ambulatory electrocardiographic recordings.

    Related Experiment Videos

    Main Results:

    • Combination therapy with nadolol and class I agents resulted in a mean 79% decrease in ventricular premature complexes (p<0.01).
    • A significant 95% reduction in ventricular couplets was observed with combination therapy (p<0.01).
    • 57% of patients achieved a positive treatment response (≥75% reduction in VPCs) with nadolol plus a class I agent.

    Conclusions:

    • Nadolol in combination with class I antiarrhythmic agents is effective in managing poorly controlled ventricular arrhythmias.
    • The combination therapy offers a viable option for patients unresponsive to class I agents alone.
    • Further research into hemodynamic effects and long-term outcomes is warranted.